Đang chuẩn bị liên kết để tải về tài liệu:
Mutations of BRCA2 in canine mammary tumors and their targeting potential in clinical therapy

Quang Hòa 21 9 pdf

Đang chuẩn bị nút TẢI XUỐNG, xin hãy chờ Tải xuống

Dogs develop cancer spontaneously with age, with breed-specific risk underlying differences in genetics. Mammary tumors are reported as the most frequent neoplasia in intact female dogs. Their high prevalence in certain breeds suggests a genetic component, as it is the case in human familial breast cancer, distinctly in BRCA2-associated cancers. |

TÀI LIỆU LIÊN QUAN

Prevalence of BRCA1 and BRCA2 pathogenic and likely pathogenic variants in nonselected ovarian carcinoma patients in Brazil

Germline mutations in BRCA1 and BRCA2 in epithelial ovarian cancer patients in Brazil

BRCA1, BRCA2 and PALB2 mutations and CHEK2 c.1100delC in different South African ethnic groups diagnosed with premenopausal and/or triple negative breast cancer

Contribution of BRCA1 and BRCA2 germline mutations to early onset breast cancer: A series from north of Morocco

Polyclonal BRCA2 mutations following carboplatin treatment confer resistance to the PARP inhibitor rucaparib in a patient with mCRPC: A case report

Association of Cytokeratin 5 and Claudin 3 expression with BRCA1 and BRCA2 germline mutations in women with early breast cancer

Targeted capture-based NGS is superior to multiplex PCR-based NGS for hereditary BRCA1 and BRCA2 gene analysis in FFPE tumor samples

**Is RNASEL:P.Glu265* a modifier of early-onset breast cancer risk for carriers of high-risk mutations**

Up-regulation of ceRNA TINCR by SP1 contributes to tumorigenesis in breast cancer

Screening of BRCA1/2 genes mutations and copy number variations in patients with high risk for hereditary breast and ovarian cancer syndrome (HBOC)

Đã phát hiện trình chặn quảng cáo AdBlock

Trang web này phụ thuộc vào doanh thu từ số lần hiển thị quảng cáo để tồn tại. Vui lòng tắt trình chặn quảng cáo của bạn hoặc tạm dừng tính năng chặn quảng cáo cho trang web này.